Inactive Instrument

Other languages ICON PLC Irish S.E.

Equities

ICLR

IE0005711209

Real-time Estimate Tradegate Other stock markets 02:32:58 2024-04-23 am EDT			5-day change	1st Jan Change
279.9 ^EUR	+1,296.01%		-8.66%	0.00%

Apr. 03	Icon CFO Brennan to Depart for Outside Opportunity	DJ
Apr. 03	Icon Says CFO Brennan Leaving in Q4, Reaffirms Guidance	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Icon Says CFO Brennan Leaving in Q4, Reaffirms Guidance	Apr. 03
Icon plc Reaffirm Earnings Guidance for the Year 2024	Apr. 03
ICON Shares Rise After Q4 Results, Guidance Reaffirmed	Feb. 22
ICON Seeks M&A	Feb. 22
ICON Q4 Adjusted Earnings, Revenue Increase; 2024 Guidance Affirmed	Feb. 21
ICON Public Limited Company announces an Equity Buyback for $500 million worth of its shares.	Feb. 21
ICON Public Limited Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21
ICON Public Limited Company Reaffirms Earnings Guidance for the Full Year 2024	Feb. 21
ICON Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21
RECOMENDACIONES DE LOS ANALISTAS EE.UU. : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
ICON Public Limited Company authorizes a Buyback Plan.	Feb. 20
ICON Public Limited Company Provides Earnings Guidance for the Full Year 2023 and 2024	Jan. 09
ICON Seeks Acquisitions	23-10-26
ICON Q3 Adjusted EPS, Revenue Rise; Full-Year Guidance Disclosed	23-10-25
Icon Public Limited Company Re-Affirms Earnings Guidance for the Full-Year 2023	23-10-25
ICON Public Limited Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-25
ICON Public Limited Company completed the acquisition of Philips Pharma Solutions for $68.1 million.	23-10-24
ICON plc Releases Expanded End-To-End Clinical Trial Tokenisation Solution	23-09-20
ICON to partner with US govt agency to test COVID-19 vaccine candidates	23-09-13
ICON plc Partners with the U.S. Biomedical Advanced Research and Development Authority to Execute Next Generation COVID-19 Vaccines Clinical Trial	23-09-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ICON PLC Irish S.E.

Equities

ICLR

IE0005711209

Other languages

Filters